Singaporean biotech startup Curiox receives US$15M investment, planning Korean IPO
Curiox Biosystems, a bio-instrumentation startup based in Singapore, announced that it has received US$15 million in its Series B funding round from Korean biotech investors, DealStreetAsia reported. The investors in the Series B funding round include KB Investment, Dayli Partners, Quad Investment Management, IMM Investment, SV Investment Partners, and HB Investment. Previously, Curiox has raised […]
The post Singaporean biotech startup Curiox receives US$15M investment, planning Korean IPO appeared first on e27.